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Abstract
The blood stage of the plasmodium parasite life cycle is responsible for the clinical symptoms of malaria. Epidemiological
studies have identified coincidental malarial endemicity and multiple red blood cell (RBC) disorders. Many RBC disorders
result from mutations in genes encoding cytoskeletal proteins and these are associated with increased protection against
malarial infections. However the mechanisms underpinning these genetic, host responses remain obscure. We have
performed an N-ethyl-N-nitrosourea (ENU) mutagenesis screen and have identified a novel dominant (haploinsufficient)
mutation in the Ank-1 gene (Ank1
MRI23420) of mice displaying hereditary spherocytosis (HS). Female mice, heterozygous for
the Ank-1 mutation showed increased survival to infection by Plasmodium chabaudi adami DS with a concomitant 30%
decrease in parasitemia compared to wild-type, isogenic mice (wt). A comparative in vivo red cell invasion and parasite
growth assay showed a RBC-autonomous effect characterised by decreased proportion of infected heterozygous RBCs.
Within approximately 6–8 hours post-invasion, TUNEL staining of intraerythrocytic parasites, showed a significant increase in
dead parasites in heterozygotes. This was especially notable at the ring and trophozoite stages in the blood of infected
heterozygous mutant mice compared to wt (p,0.05). We conclude that increased malaria resistance due to ankyrin-1
deficiency is caused by the intraerythrocytic death of P. chabaudi parasites.
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Introduction
Malaria is caused by transmission of the protozoan parasite
Plasmodium, and kills almost 1 million people annually, and
affects a further 300–500 million (WHO 2010). Multiple
epidemiological studies in human populations have shown that
host genetics is a major determinant in the susceptibility to malaria
infection. [1–3]. Numerous variants and mutations have been
identified that associate with survival and impaired parasite
growth, including several polymorphisms in genes encoding
erythrocyte-expressed proteins [4–8]. For example the erythrocyte
Duffy antigen receptor for chemokines (DARC), encoded by the
FY gene, is necessary for the invasion by P. vivax of RBCs [9–11]. A
mutation in the GATA motif of the FY promoter prevents
erythrocyte expression of FY. This mutation is common in African
populations and confers protection against P. vivax infection [12].
The cytoskeleton of erythrocytes has been a major interest in
red cell biology for decades as multiple disorders arise from
mutations in cytoskeletal components [13]. Several such red cell
disorders are also associated with resistance to malarial infection
[14–18]. For example, individuals with hereditary elliptocytosis
have deficiencies in either protein 4.1 or glycophorin C and have
been reported to show resistance towards malaria infections [19].
Other RBC disorders such as hereditary spherocytosis (HS)
[13,20] have also shed light into the host-parasite interaction
due to their involvement in malaria pathogenesis [21,22].
However the elucidation of the mechanisms of resistance mediated
by changes to these host erythrocytic proteins remains incomplete.
The murine host response to a malarial infection is faithful to
the human response to human malarias [23–26]. Mouse models of
malaria have been used to study genetic factors that determine the
host response to infection and to identify novel mechanisms that
confer protection against Plasmodium [27,28]. Similar to humans,
there is considerable variability in either the rate of development of
blood parasitemia or outcome to infection in different inbred
mouse strains [29–31]. Beside the identification of several
quantitative trait loci that determine susceptibility towards rodent
malarial infection, investigation of various mouse mutants have
revealed novel genes associated with malaria pathogenesis [24,30–
33]. Given the difficulty identifying genes underpinning quantita-
tive trait loci, we have employed a complementary approach using
N-ethyl-N-nitrosourea (ENU) to generate random point mutations
in mice to identify novel genes and mechanisms that underlie
susceptibility to malaria infection. This strategy has been
previously employed to decipher the genetic architecture deter-
mining several phenotypes [34,35] including other infectious
diseases [36-38]. In our ENU mutagenesis screen, we aimed to
identify novel mutations that increase the resistance of an
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1,2otherwise susceptible strain of mouse to a malarial infection. We
describe here an ENU-mutant line of mouse with increased
survival to P. chabaudi adami DS infection, carrying a novel
hypomorphic mutation in the Ank-1 gene (Ank1
MRI23420).
Ankyrin-1 is a large (210 kDa) cytoskeletal protein encoded by
the Ank-1 gene and is found predominantly in the erythrocyte
membrane. Mutations in human Ank-1 have been studied for their
role in the inherited hemolytic anaemia disorder, HS [20]. Over
50% of HS cases are caused by mutations in this gene [39].
Recently, Ank-1 has been investigated for its role in malaria
infections using a naturally occurring mutant (Ank-1
nb) [17] and an
ENU generated mutant (Ank-1
1674) mouse line [14]. Both of these
mutations result in an abnormal ankyrin-1 protein in the
erythrocyte. Mutant mice carrying these mutations are more
likely to survive infections from P. chabaudi and P. berghei [14,17].
However the role of mutant ankyrin-1 in conferring increased
resistance remains a point of conjecture. Studies have variously
suggested that merozoite release, [40–42] parasite invasion [17]
and intraerythrocytic development [17] may be affected, although
the evidence for these is not conclusive.
In this study we aimed to further characterise the mechanistic
basis of malarial resistance imparted by ankyrin-1 deficiency
through the analysis of the Ank1
MRI23420 mouse line. We present
novel evidence that maturation of intracellular P. chabaudi parasites
is impaired in ankyrin-1 deficient RBCs. Although we cannot
exclude other contributions such as splenic clearance we conclude
that parasite growth retardation is the major mechanism
contributing to the resistant phenotype observed in Ank-
1
MRI23420/+ mice.
Results
Identification of a Novel ENU Ank-1
MRI23420 Mutation
The ENU mutant line MRI23420 was generated during a
screen for dominant ENU-induced mutations that affect RBCs in
an inbred line of mice, SJL/J. Full automated blood analysis was
conducted on samples collected from G1 animals at 7–8 weeks of
age. The line MRI23420 was identified based on a mean
corpuscular volume (MCV) that was 3 standard deviations less
than the normal population (MCV=45.260.2 fl in mutant versus
MCV=52.060.4 fl in wild type mice; p-value ,0.001) (Table 1).
The mutation was mapped by backcrossing SJL/J mice
exhibiting the mutant phenotype to C57BL/6 animals. Using an
affected-only mapping strategy, progeny (F1s & N2s) were selected
on the basis of an MCV ,50.0 fl and DNA analysed using
genome-wide SNP genotyping (20 affected N2 mice using 300
polymorphic SNPs). Linkage analysis identified a region on
chromosome 8 shared by all affected N2 mice (LOD =5.11),
and the critical interval was further defined using microsatellite
mapping to a region 22 - 25 Mb from the centromere (Fig. 1A).
Within this interval, the Ank-1 gene was selected as a candidate
and sequencing the affected G1 founder mouse revealed a single
heterozygous mutation, which was also present in the affected N2
animals. The mutation, a single point transversion (T A) in exon
11 at nucleotide position 1265 of Ank-1 (Fig. 1B), creates a
premature termination codon at position 422 predicted to produce
an ANK-1 protein truncated within the band 3 binding domain
(Fig. 1C &1D).
To investigate the effect of the mutation on Ank-1 expression, we
conducted immuno-blotting on whole blood lysates from wt, Ank-
1
MRI23420/+ and Ank-1
MRI23420/MRI23420 mice. A 210 kDa anti-
mouse ANK-1 immunoreactive band, corresponding to the full-
length protein, was observed in samples from the wt and
heterozygous mice, while this band was not detected in the
homozygote mice (Fig. 2A and 2B). A smaller band (,50 kDa) was
also present in the heterozygous and homozygous mutant samples,
closely matching the theoretical size of the truncated form of
ankyrin-1 (49 kDa; Fig. 2A). Quantification of these immunore-
active bands revealed reduced levels of the full-length protein in
Ank-1
MRI23420/+ blood cells compared to wt cells, while Ank-
1
MRI23420/MRI23420 cells displayed a greater amount of the
truncated form compared to their heterozygous relatives. To
assess if a compensatory mechanism substitutes for the lack of
functional protein, a quantitative PCR was conducted using two
ANK-1 primers spanning before and closely after the ENU
mutation (Fig. S1A and S1B). Relative quantification of Ank-1
mRNA expression in different tissues found significantly elevated
levels of transcript in some Ank-1
MRI23420/+ tissues. In the spleen
and in the brain, the transcript level of Ank-1
MRI23420/+ is
respectively 4 and 2.5 fold over expressed and 0.7 fold under
expressed in the kidney. No differences were found on transcripts
level in the liver.
The ENU Blood Mutant MRI23420 Displays an Hereditary
Spherocytosis Phenotype
The observed frequency of 10% live births of homozygous
littermates compared to an expected 25% suggesting that mice
homozygous for the mutation are embryonic or neonatal lethal.
Ank-1
MRI23420/MRI23420 mice displayed severe jaundice and had a
life expectancy of only 12–48 h (Fig. 3C). Autopsy revealed
distinct splenomegaly (spleen weight divided by body weight in wt
mice 5.560.4 g versus 7.160.6 g in Ank-1
MRI23420/MRI23420,p -
value ,0.05) and Giemsa stained blood smears showed distinct
amorphous poikilocytosis with marked spherocytes, severe RBC
fragmentation, and increased immature RBCs (Fig. 3D). Due to
the severity of their phenotype, homozygote mice were not subject
to malarial studies.
Heterozygous Ank-1
MRI23420/+ mice displayed a slight spleno-
megaly (0.1160.03 g for wt mice versus 0.1660.01 g for
heterozygous mice; p-value ,0.05). Histological examination
revealed changes in the splenic architecture with a reduced
medulla and a proliferation of the extramedullary compartment
Table 1. Haematological parameters on wild-type and Ank-1
MRI23420/+ mice.
WBC RBC HGB HCT MCV MCH MCHC RDW PLT %Retic
Wild-type 6.160.1 5.160.1 70.461.7 0.2560.01 53.460.2 15.760.5 293.968.3 15.460.1 498.367.8 2.560.2
Ank-1
MRI23420/+ 6.160.2 5.560.1** 72.061.4 0.2660.02 45.360.1** 13.660.3** 285.765.9 15.560.1 540.6613.4* 3.060.2
Automated full blood analyses were obtained on 69 wt and 72 Ank-1
MRI23420 mice at 7 weeks of age. Values are represented as mean value 6SEM. Statistical differences
are indicated as (*) p-value ,0.05 and (**) p-value,0.001. WBC indicates white blood cell count; RBC, red blood cell count; HBG, hemoglobin; HCT, hematocrit; MCV,
mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW, red cell distribution width; PLT, platelet
count; and %Retic, %Reticulocytosis.
doi:10.1371/journal.pone.0038999.t001
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revealed extramedullary iron deposition (Fig. S3A and S3B).
Quantification of non-heme iron (Fig. S3C) demonstrated an
almost 2 fold increase in iron deposition in the spleen of
heterozygous mice consistent with an iron overload phenotype.
Hematological analysis of the heterozygous mutant mice revealed
a number of red cell abnormalities (Table 1) including a marked
microcytosis and mild polycythemia. This was confirmed in
peripheral blood smears, where small, hyperchromic red blood
cells were observed (Fig. 3A,B). Scanning electron microscopy
imaging revealed that over half (68.9617.4%) of the red cells in
Ank-1
MRI23420/+ mice were severely deformed with obvious
membrane blebbing, although no fragmentation was seen. By
comparison wt controls exhibited 6.2563.95% of abnormal
RBCs (Figure 4B-D). To investigate this further, we conducted
osmotic fragility assays and found that cells from heterozygous
mice lysed at significantly higher salt concentrations than wt
(Fig. 4A). In concert with the observed anaemic phenotype we
observed an almost two-fold increase in serum levels of the
erythropoietin, the hormone controlling erythropoiesis in Ank-
1
MRI23420/+ mice (530.7647.7 pg/ml; p-value ,0.001) compared
to wt (278.3624.9 pg/ml). Several cases of Ank-1 mutations in
both human and mice have been reported in the literature and
all of them have been associated with a HS phenotype exhibiting
anaemia, splenomegaly, and a higher osmotic fragility in RBCs
[14,39,43,44].
Ank-1
MRI23420/+ Mice are Resistant to Malaria Infection
We sought to characterise the effect of the Ank-1
MRI23420
mutation in a malarial infection. Heterozygous and wt mice of
both gender were challenged with a normally lethal dose of P.
chabaudi adami DS. A dramatic increase in survival of the Ank-
1
MRI23420/+ mice compared to wt SJL was observed in both males
and females (p,0.001 and p,0.0001, respectively, using a
Mantel-Cox test); the respective mortality rates for each sex were
6% (females) and 38% (males) for Ank-1
MRI23420/+ and 90%
(females) and 100% (males) for SJL mice (Fig. 5A-B). Further we
monitored the development of blood parasitemia. The proportions
of infected RBCs in mutant animals of both sexes peaked at a
significantly lower level and later time (one or two days) compared
to wt (Fig 5C-D). Therefore as well as acting dominantly to cause
an HS-like phenotype, a single copy of the Ank-1
MRI23420 mutation
also results in a dramatically enhanced resistance to malaria
infection.
Figure 1. Identification of the Ank-1MRI23420 allele. (A) Haplotypes of 2nd generation offspring. Narrowing down critical interval using
microsatellites on chromosome 8. Grey boxes represent heterozygous and white boxes homozygous mice. The candidate interval for Ank-1MRI23420
was refined to 22–25 Mb on Chr. 8. (B) DNA sequence electropherograms showing the T to A transversion in exon 11 for wt, Ank-1MRI23420/+ and
Ank-1MRI23420/MRI23420 mice. (C) Schematic view of the amino acid change. (D) Representation of the position of the mutation within the protein.
doi:10.1371/journal.pone.0038999.g001
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MRI23420 Malaria Resistant Phenotype is due to a
Red Cell Autonomous Effect
To assess the contribution of abnormal red cells and possible
secondary effects of the mutation (eg. altered splenic function) in
the malaria resistant phenotype, we developed an in vivo parasite
invasion and growth assay. RBCs isolated from uninfected wt and
Ank-1
MRI23420/+ mice were labelled with individual fluorescent
markers (ATTO-495 and -633), mixed in equal proportions and
injected back into the bloodstream of infected recipient mice of
either genotype (wt and Ank-1
MRI23420/+). Following a period to
allow for parasite reinvasion, samples were collected and examined
for the proportion of infected cells of each labelled population
growing in animals of each genotype (Fig. S4A-B). The results
revealed a significant decrease in the proportion of infected cells
from the Ank-1
MRI23420/+ line compared to wt (p,0.0001; Fig. 6).
This difference was observed irrespective of dye used to label each
type of cell, and occurred independently of the genotype of the
recipient animal. Therefore, the Ank-1
MRI23420 mutation appears
to confer the resistant phenotype by directly affecting the ability of
the host red to support either invasion, egress and/or growth of
the parasite. However, we also observed a modest but significant
increase in spleen weight in infected mutant mice around the time
of peak parasitaemia (0.3060.03 g for wt versus 0.8260.10 g for
Ank-1
MRI23420/+, p-value ,0.05), consistent with increased splenic
clearance of RBCs. We believe that this does not significantly
affect the clearance of abnormal cells from the circulation as the
proportion of infected cells of either genotype was not dependent
on the background. However it is possible that infected cells are
cleared more in mutant mice, but this would be similar for both
mutant and wt cells. This observation may also be related to the
underlying different baseline splenomegaly present in these mice
(see above).
Intraerythrocytic Parasites Die during Infection in Ank-
1
MRI23420/+ Mice
After merozoites invade RBCs malaria parasites transform into
ring forms and subsequently develop into trophozoites that
undergo nuclear divisions becoming mature schizonts. In the case
of P. chabaudi the parasites intraerythrocytic life cycle lasts 24 hours
[45] and the parasites show a synchronous growth cycle at low
parasitemia.
During our observation of the parasites’ asexual life cycle under
a light microscope it became noticeable that when compared to wt
RBCs, a significant larger proportion of parasites in mutant RBCs
were smaller and pyknotic. This phenomenon was visible 6–8
hours (37.4% 66.3 in Ank-1
MRI23420/+ vs. 17.6%61.1 in wt RBC `s;
p-value ,0.05) (Fig. 7A and 7B) and 18–20 hours (40.7% 8.0 in
Ank-1
MRI23420/+ vs. 16.3%62.2 in wt RBC `s; p-value ,0.05
(Fig. 7C and 7D) post-invasion. From this observation we
speculated that parasites are less healthy while growing in mutant
RBCs and hypothesised that P. chabaudi may suffer from retarded
development during the erythrocytic life cycle in Ank-1
MRI23420/+
mice. Further we observed that in Ank-1
MRI23420/+ compared to wt
RBCs parasite replication was noticeably lower after 18–20 hours
post-invasion (Fig. S5).
Figure 2. Protein levels of ankyrin-1 analysis. (A) Immunoblot of erythrocytic ankyrin-1 in wt, Ank-1MRI23420/+, and Ank-1MRI23420/2340 mice
with the N-terminal antibody ANK-1 p89. Quantification of the intensity of bands by densitometry for full-size ankyrin-1 (210 kDa) (B) and the
truncated species (C) (calculated size 49 kDa). Error bars indicate SEM.
doi:10.1371/journal.pone.0038999.g002
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stain procedure adapted to detect sheared or fragmented DNA,
indicative of dying or dead intraerythrocytic parasites (Fig. 8A-C)
[46]. Compared to wt, a significant increase of almost two-fold
(,0.05 p-value) in dead parasites was apparent in blood taken
from mutant mice approximately 6–8 hours after parasite
invasion. The proportion of dead parasites in mutant compared
to wt mice remained significantly higher 12 hours later (18–20
hours post-invasion) wt (p-value ,0.05) (Fig. 8D). This is
consistent with our observation of morphologically compromised
parasites in mutant cells at both time points and the lower parasite
replication rate noticed after 18–20 hours post-invasion. Together
this suggests an increased death rate of parasites during their
development within Ank-1
MRI23420/+ RBCs.
Discussion
In this study, we identified a novel ankyrin-1 mutation and
characterized several associated hematological phenotypes. Fur-
ther we investigated the mechanism of malaria resistance seen in
these ankyrin-1 deficient mice. For the first time, we demonstrate
that a mutation in the Ank-1 gene decreases susceptibility to
malaria by reducing survival of P. chabaudi in affected RBCs.
Ankyrin-1 protein is a crucial component of the RBC
cytoskeletal complex and its deficiency is responsible for the most
common type of human hereditary spherocytosis (HS) [20,39,47].
Likewise, mice lacking a functional form of the ankyrin-1 protein
also share most of the signs and symptoms of human HS
[14,43,48]. In this report, we demonstrate that our novel ENU-
induced mutation in Ank-1
MRI23420 mice displays a clinical
phenotype mostly consistent with the HS Ank1
E924X mouse model
[43]. It has more pronounced symptoms than either the recessively
inherited Ank1
nb mutation [48] and the null mutant Ank1
1674 [14].
Notably Ank-1
MRI23420 homozygous mice exhibit a 100% postnatal
death rate with severe signs of jaundice due to massive hemolysis.
Heterozygous Ank-1
MRI23420/+ mice display a regenerative anae-
mia and splenomegaly with iron overload. The closest human
counterpart to the Ank-1
23420 murine mutation is the Ank-1
Bari
mutation which has a frame-shifting deletion in exon 12 leading to
a truncated protein. Interestingly, and similar to the Ank-1
MRI23420
Figure 3. Identification of Ank-1
MRI23420/+ and Ank-1
MRI23420/23420 mice. Giemsa stained peripheral blood smears from (A) wt, (B) Ank-1
MRI23420/+,
and (D) Ank-1
MRI23420/MRI23420 mice. Black arrows indicate microcytic RBC in Ank-1
MRI23420/+ and spherocytes in Ank-1
MRI23420/23420. (C) Jaundiced
postnatal day 1 of Ank-1
MRI23420/MRI23420 pup and an Ank-1
MRI23420/+ control littermate.
doi:10.1371/journal.pone.0038999.g003
P. chabaudi Dies in Ankyrin-1 Impaired Red Cells
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38999phenotype, humans with the Ank-1
Bari mutation have a more
severe phenotype than other human ankyrin-1 mutations [44].
Despite the differences in the phenotypic severity between the
murine HS models all shared several hematological symptoms.
This includes an increased RBC count, increased osmotic fragility
and red cell deformity. Therefore, this novel ENU-induced
mutation represents another model for the trial of preclinical
therapeutic interventions for the treatment of affected individuals
with dominant inherited HS.
Importantly, heterozygous Ank-1
MRI23420 mice exhibited a
dramatic increase in resistance towards malaria. Previous studies
focused on two different Ank-1 mice carrying different mutations in
the regulatory domain of the protein; the normoblastosis mutation
(Ank-1
nb) [48] and Ank-1
1674 (Rank et al. 2009). Both of these
strains exhibit HS and also display a survival advantage to
Plasmodium chabaudi infection [14,17]. However, the ENU-induced
Ank-1
MRI23420/+ mice exhibited a delay in the rise of peak
parasitemia and a more dramatic reduction in the height of the
peak (at least 20 to 40%) compared to heterozygous Ank-1
nb mice
(10%). Increased malaria resistance was initially observed 20 years
ago in the Ank-1
nb mice; however the mechanism underpinning
malaria resistance in mice carrying ankyrin-1 mutations remains
elusive. Rank and colleagues [14] examined several potential
mechanisms including a hypothesised impaired invasion mecha-
nism of the parasite into RBCs. Despite their efforts no differences
in invasion efficiency or altered RBC survival between mutant and
wt was found. The only possible functional difference between
Ank-1
1674 and wt mice was a significant increase in osmotic
fragility in affected RBCs. This could possibly result in an
increased clearance of infected mutant cells from the circulation by
the spleen.
A postulated impairment of parasite invasion into ankyrin-1
deficient RBCs has received considerable attention. This is not
surprising considering that the observed increase in osmotic
fragility and deformity in ankyrin-1 deficient RBCs is likely to
disrupt an association between the cytoskeleton and invading
parasite. In support of this hypothesis, elliptocytic RBCs with
protein 4.1 and glycophorin deficiencies have been reported to
inhibit P. chabaudi entry. In contrast is the study by Rank and
colleagues [14] which did not find evidence for this mechanism
using an in-vitro invasion assay system with P. berghei as a parasite
model. Nevertheless by injecting a 1:1 mix of both host
fluorescently labelled RBCs into wt and Ank-1
MRI23420/+ mice in
an in-vivo assay system we demonstrated that Ank-1
MRI23420/+
RBCs were significantly less likely to be infected than wt in a cell-
autonomous manner. So far we cannot conclude from our results if
the decrease in infectivity is due to impaired invasion as we cannot
rule out other contributions such as impaired schizogony due to
growth retardation or clearance from the circulation. However the
latter explanation is unlikely given that it would have to be young
ring-stage parasites that were being cleared. Therefore it remains
open if a deficiency of ankyrin-1 in RBCs perturbs invasion of
malaria parasites.
However we noticed that intraerythrocytic parasites appeared
morphological abnormal in Ank-1
MRI23420/+ RBCs. The parasites
growing in mutant cells were noticeably condensed and smaller 6–
8 hours after invasion. The same phenomenon was observed at
trophozoite stage (18–20 hours post-invasion). Given that this may
represent parasite death, we investigated the health of P. chabaudi
parasites in vivo using the TUNEL stain. The proportion of
TUNEL stained dead parasites was significantly greater at ring
and trophozoite stage in Ank-1
MRI23420/+ RBCs compared to wt.
From those results we conclude that deficiency in ankyrin-1 results
in increased death of the intraerythrocytic parasites which
inversely affects the course of parasitemia resulting in resistance
to malarial infection.
A previous study on the P. falciparum and human RBCs
suggested that ankyrin-1 plays a role at the late stages of parasite
development (Hanspal, 2002). In this process, falcipain-2 of the
cysteine protease family cathepsin [49] was shown to cleave
ankyrin-1 and protein 4.1 in RBCs [41]. In support another study
found that several proteins associated with the RBC cytoskeleton
including ankyrin-1 are proteolysed during merozoite release [50].
To demonstrate a functional role of ankyrin-1 in merozoite
release, a synthetic peptide spanning the identified cleavage site of
the cytoskeletal protein (amino acid 1210), prevented falcipain-2
activity and subsequent development of P. falciparum trophozoites
into segmented schizonts and subsequent rings. Our results
demonstrating a growth arrest of parasites at trophozoite stage
provides in vivo support to their hypothesis that ankyrin-1 is
important for trophozoite development.
In addition we noticed that survival of intraerythrocytic
parasites was reduced at ring stage. The observation from both
Figure 4. Hematological phenotype of Ank-1
MRI23420/+ RBCs. (D)
Osmotic fragility plot of wt, heterozygous and homozygous mice.
Scanning electron microscope imaging of peripheral blood from (B)
Ank-1
MRI23420/+ and (C) wt uninfected mice. The white arrow indicates
erythrocyte membrane blebbing and deformity. (D) Enumeration of the
proportion of normal and abnormal RBCs observed with error bars
indicating SEM.
doi:10.1371/journal.pone.0038999.g004
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that parasites begin dying as early as 6 hours after invasion
indicates that survival of parasites in mutant RBCs is affected
before trophozoite development. This contrasts to the study from
Dhawan and colleagues [40] showing that ring stage parasites
incubated with the anti-ANK-1 peptide, matured to trophozoites
comparably to their control group. Our observation would suggest
that decreased ankyrin-1 levels affect the parasite `s survival in
RBCs via mechanisms additional to falcipain-2 cleavage.
Several studies have suggested that abnormal cytoskeletal
proteins of RBCs may disrupt survival of intraerythrocytic
parasites [15–17]. Pantaleo and colleagues [51] have reported
that phosphorylation of several RBC membrane proteins,
including band 3 and ankyrin-1, is influenced by the parasite
during maturation. They speculated that the observed phosphor-
ylative changes of cytoskeletal proteins including ankyrin-1 may be
a response to perturbation of RBC homeostasis during parasite
growth. However, these did not address any functional conse-
quences of these changes. To our knowledge this is therefore the
first evidence that increased resistance of Ank-1 impaired mice is
most closely related to intraerythrocytic parasite growth rates
during the initial expansion in circulating parasite mass and this is
consistent with a red cell autonomous effect.
In summary we generated a novel ENU-mutation in Ank-1
resulting in an HS phenotype in mice. We demonstrated that a
decrease in ankyrin-1 protein levels reduced susceptibility to
malaria infections. Furthermore we revealed that P. chabaudi
parasites display reduced growth and probably invasion and/or
egress capacity in RBCs exhibiting ankyrin-1 abnormalities. The
importance of ankyrin-1 during the parasites maturation stage
gives us further insights into the understanding of the molecular
interactions between the parasite and its host cell. This study
provided also the first direct evidence that a cytoskeletal host
protein plays a crucial role in parasite maturation. Further it
highlights the importance of host mediated genetic resistance from
cytoskeletal protein abnormalities towards malaria resistance.
Materials and Methods
Mice and Ethics Statement
All mice in this study were housed under controlled temperature
(2161uC) with a 12:12 h light-dark cycle. All procedures were
conducted in accordance with the policies of the University of
Tasmania and conformed to the National Health and Medical
Research Council (NHMRC) Australian code of Practice. The
work was performed under the agreement Ethics No A0104070
approved and obtained from the Animal Ethics Committee at
University of Tasmania.
Figure 5. Ank-1
MRI23420/+ mice display resistance towards malarial infections. Kaplan Meier survival curve for (A) female and (B) male animals.
Number of infected RBCs in (C) female and (D) male mice. Infection dose was 4610
4 and 2610
4 for female and males respectively. Error bars indicate
SEM and statistical differences are marked with a student `s t-test p-value ,0.05 (#), p-value ,0.01 (*), and Mantel Cox Log rank with p-value ,0.001
(**) and p-value ,0.0001 (***).
doi:10.1371/journal.pone.0038999.g005
Figure 6. Infection rate of P. chabaudi in Ank-1
MRI23420/+
compared to wt RBCs is impaired. Uninfected RBCs from wt and
Ank-1
MRI23420/+ mice were labelled individually with different fluorescent
dyes mixed at a 1:1 ratio and injected into infected animals of both
groups. 10 hours later tail blood was taken and analysed on flow
cytometry gating for infected RBCs +ve for either dye (ATTO 633 & 495).
Results were calculated as the mean of normal and reversible labelled
RBCs from each group for each background separately. Error bars are
presented as SEM and (*) indicate statistical differences with a p-value
,0.0001.
doi:10.1371/journal.pone.0038999.g006
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SJL/J male mice received two intraperitoneal injections of
150 mg/kg ENU (Sigma-Aldrich, Oakville, ON, Canada) at one
week interval. Mutagenized SJL/J males (G0) were crossed to
SJL/J females and the first generation progeny (G1) were screened
for a peripheral blood (PB) phenotype from seven weeks old on an
Figure 7. Impaired phenotype of P. chabaudi parasites in Ank-1
MRI23420/+ RBCs. Giemsa stained blood smears showing the morphology of
parasites in wt and Ank-1
MRI23420/+ mice 6–8 hours (A-B) and 18–20 hours (C-D) post-invasion. Black arrows indicate condensed phenotype of
intraerythrocytic parasites observed in heterozygous mutant mice.
doi:10.1371/journal.pone.0038999.g007
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Hematology Analyser). Mice with a ‘‘mean corpuscular volume’’
(MCV) parameter deviating from littermate over 3 standard
deviations below the average of the G1 mice were selected and
tested for their heritability through SJL/J progeny testing (G2). A
student’s t-test was performed to assess statistical differences for all
parameters. For genetic mapping G2 animals were backcrossed to
C57BL/6 mice. F1 were screened for their microcytic MCV
phenotype and affected F1 were mated with C57BL/6J strain to
produce N2 generation mice that were also screened for their
MCV.
Gene Mapping
Genomic DNA was purified from the tail using the phenol
chloroform extraction procedure described by Kochl et al. [52]. A
genomewide SNP analysis on a MASSarray platform using the
IPlex GLOD technology (Sequenom Inc, San Diego, CA) was
conducted on 20 affected N2 mice using a mouse linkage marker
set of over 600 SNPs markers including 300 polymorphic ones
between C57BL/6 and SJL/J evenly distributed throughout the
genome. The lod score was determined by using a chisquare test
between observed values (number of heterozygous genotype mice
per SNP) and theoretical values. Fine mapping of the critical
interval was conducted with microsatellites genotyping of recom-
binant mice for chromosome 8 between 22 and 44 Mb
(D8Mit170a, D8Mit95, D8Mit190, D8Mit65). Sequencing of the
Ank-1 gene was done by amplification of all exon and intron/exon
boundaries using the polymerase chain reaction (PCR). For a
single PCR 12.5 mL of GoTaq Green Mastermix containing Taq
polymerase, magnesium chloride, DNTPs, and the loading buffer
(Promega, Madison WI), 5.5 mL of distilled H20, 1 mL of each
specific primer (concentration 10 mmol/L), and 5 mL of the
corresponding DNA sample (concentration of 20 ng/mL) were
used. PCR products were purified using a DNA clean up kit
(Promega Corporation, Madison WI) before sent for Sanger
sequencing at the Australian Genome Research Facility (AGRF).
SDS Page and Western Blot Analysis
For Western blotting whole blood lysate samples were separated
by non-denaturing sodium dodecyl sulfate–polyacrylamide gel
Figure 8. Evidence that maturation of P. chabaudi in Ank-1
MRI23420/+ RBCs is impaired. (A) Nuclear yellow staining of parasite DNA. (B) TUNEL
staining of fragmented parasite DNA, and (C) merged TUNEL and nuclear yellow staining superimposed on brightfield showing infected RBC. (D)
Percentage of double positive for nuclear yellow and TUNEL stained parasites in regards to overall parasitemia in RBCs of both cohorts. Blood was
collected 6–8 hours (ring stage) and 18–20 hours after invasion (trophozoite stage). Error bars indicate SEM and statistical differences with a p-value
,0.05 were indicated by (*).
doi:10.1371/journal.pone.0038999.g008
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immunoblotting, samples were transferred to nitrocellulose mem-
branes. The membrane was then incubated with either the mouse
monoclonal GAPDH (Milliporo) or the N-terminal Ank-1 antibody
‘‘p89’’ (kindly provided by Connie Birkenmeier, Jackson Labora-
tory, USA) and then washed extensively prior to incubation with
peroxidase-conjugated secondary antibodies. After further washes,
the blots were visualized using enhanced chemiluminescence
(ECL) reagents (Amersham Biosciences, Piscataway, NJ).
Densitometry analysis was done in Photoshop CS4 (Adobe).
Each band was masked containing equal amount of pixel and the
mean from the histogram recorded. Values were subtracted from
background and divided by the signal from corresponding
GAPDH bands.
Quantitative PCR
RNA was isolated from kidneys, spleens, brain and livers of
uninfected SJL and Ank-1
MRI23420 heterozygous mice using the
Tri-reagent (Invitrogen, Carlsbad, CA) according to the manu-
facturer’s recommendations. RNA was cleaned-up using the
Qiagen midi kit (Qiagen, Valencia CA) and reverse transcribed
with the cDNA synthesis kit (Roche-Applied Science, Basel,
Switzerland) with Oligo-p(dt)15 primers. Quantitative PCR of
cDNA was conducted using the SYBR green fluorescent dye
(Roche, Basel, Switzerland) at a serial concentration from 1:10 to
1: 160. The gene expression study was conducted on a Light
Cycler 480 (Roche, Basel, Switzerland). The expression of the
gene Ank-1 was normalised to ß-Actin using the 2
2DDCt formula
and expressed as a fold change of the wild-type mice. Primers from
Ank-1 gene were spanning throughout the gene on the exons 6 and
17. The primers sequences are: Ank-1_1, 59-CTACAGCAGGGT-
CACGAGAA-39; Ank-1_1, 59-GTCCGTGTGTCATCGTTGC-
39; Ank-1_2, 59-TGCCAAGCAGAACCAGATAG-39; Ank-1_2,
59-AGTGGGGTCACGCCTTGTA-39; ß-Actin, 59-
TTCTTTGCAGCTCCTTCGTTGCCG-39; ß-Actin, 59-
TGGATGCGTACGTACATGGCTGGG-39.
Histology
Spleens and livers from uninfected SJL and Ank-1
MRI23420/+
mice were collected and fixed overnight in 10% formalin for 24
hours, dehydrated on the Leica ASP200 S Tissue Processor (Leica
Microsystems) and embedded in paraffin wax. Sections were cut
on a microtome at 5 mM and fixed to glass slides and then stained
with either hematoxylin-eosin or Perl’s Prussian Blue staining.
Total Non-heme Assay in Mouse Tissue
Liver and spleen tissue were dissected from uninfected animals.
Between 50–100 mg of each tissue was dried at 45uC for 48 h
hours and placed in 10% Hydrochloric acid/10% Trichloroacetic
acid solution to digest for 48 hours at 65uC. Samples were then
centrifuged at 13 `000 rpm for 5 minutes. 200 ml of supernatant was
then added to 1 ml of 1,10-Phenanthroline monohydrate solution
(Sigma-Aldrich) and incubated for 15 minutes at room temper-
ature. After incubation 300 ml of sample was transferred to a flat
bottom plate and absorbance measured at 508 nm. All samples
were duplicated and for all statistical analyses a student `s t-test was
performed.
Scanning Electron Microscopy
One to two drops of tail venous blood were sampled from
uninfected and infected mice at low parasitemia (3–8%) displaying
synchronised ring stage. The blood was collected in 1 ml of 1x
MT-PBS (pH 7.2) and centrifuged at 500 rpm for 5 minutes at
room temperature. The pellet was then fixed in 1 ml of 2.5%
glutaraldehyde for 1 h under constant agitation before stored at
4uC for up to 3 days until further processing. Cells were placed on
THERMANOX coverslips (ProSciTech - Queensland) and
postfixed with 2.5% osmium tetroxide (OsO4) for 30 minutes at
room temperature. Samples were rinsed 2–3 times in 10% EtOH
before dehydrated through a number of incubations with
increasing concentrations of ethanol (10 minute changes in each
of 30, 50, 70, 80, 90, 95, 100, 100% EtOH, 100% dry EtOH, and
100% dry acetone). Thereafter samples were critical point dried
with a 30 minutes purge time (tousinis autosanwdri-815) and
mounted on metal stups with a carbon disk underneath. Edges
were sealed with carbon paint for better conductivity and samples
were sputtercoated with a 6 mm platinum layer (Cressington
sputter coater 208HR with Cressington thickness controller
mtm20). Imaging was carried out using a JEOL JSM-6701F
scanning electron microscope.
Cells were quantified by counting morphologically similar cells.
Normal RBCs (Fig. 9A) were defined as displaying a classic round
donut shape with an obvious centre depression and no blebs visible
on the surface. Abnormal RBCs (Fig. 9B) were specified if they
possessed distinct blebbing of the surface responsible for a
complete loss of a round cell structure and the centre depression.
Osmotic Fragility
Fresh blood was collected from 7 week old heterozygous and wt
mice and incubated in different NaCl concentrations (from 0 to
160 mmol) for 30 min at 37uC. After gentle centrifugation,
supernatant was taken and the absorbance was measured at
540 nm. The absorbance of each sample in water was recorded as
100% lysis.
Erythropoietin Immunoassay
Blood was collected from adult uninfected wt and Ank-
1
MRI23420/+ mice and left to clot at room temperature for 2 hours.
Samples were centrifuged at 2000 g for 20 min and serum
removed. A Quantikine Mouse/Rat Immunoassay (R &D
Systems, Minneapolis) was used to measure the concentration of
erythopoiesin (EPO) according to manufacturer instructions.
Malaria Infection with P. chabaudi
The rodent malarial parasite species P.chabaudi adami DS was
used for all experimental infections. 250 mL of thawed parasite
stocks were injected into the intraperitoneal cavity of C57BL/6
donor mice. When donors reached 5–15% parasitemia, blood was
Figure 9. Examples of the defined morphology of RBCs in the
quantification of mis-shaped RBC with SEM. (A) normal RBC and
(B) abnormal RBC.
doi:10.1371/journal.pone.0038999.g009
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blood was then diluted into 25 ml of HEM (HEPES-buffered
minimum Essential Media) which consisted in Mini Essential
Media (MEM) +2% of 1M HEPES and 1% Penicillin from total
volume and pre-heated to 37uC to give a final parasite
concentration of 1610
4 parasitised RBCs. Mice were monitored
daily by Giesma stained blood smears from tails. Thin smears were
fixed in methanol for one minute, following with ten minutes in
10% Giemsa. Parasitised RBCs were then examined under a light
microscope at 100x magnification and the percentage of infected
to uninfected RBCs calculated. Survival challenges were split by
gender as males are known for their increased susceptibility to P.
chabaudi infections [54,55]. Statistical analysis for malarial survival
was determined by a Mantel-Cox log rank test on a Kaplan-Meier
survival curve using Prism 5.04 (Graphpad). A student `s t-test was
performed for all parasitemia screens.
For the erythrocytic parasite stage assay one drop of tail blood
was sampled at 8 am and 8 pm. The assay was conducted at low
parasitemia (starting at 2–4%) displaying the more likely
synchronised parasites. Around 500–600 infected RBC displaying
ring or trophozoite stage were counted per slide under a light
microscope (magnification 6100). A separate count as described
above was done for evaluating total parasitemia as described
above.
Invasion/growth in-vivo Assay
Fresh blood was collected from at least 7 weeks old uninfected
wt and Ank-1
MRI23420/+ mice. RBCs were concentrated by
centrifugation. Wt and Ank-1
MRI23420/+ RBCs were stained with
the fluorescent dyes, ATTO 633 and 495 (Sigma Aldrich, St
Louis, Missouri) in all possible combinations (wt-ATTO 633, wt-
ATTO 495, Ank1
MR23420/+-ATTO 633 and Ank1
MRI23420/
+-ATTO 495). The blood was stained with the dyes according to
manufacturer instructions. Stained cells were mixed into the
following combinations: wt-ATTO 633 with
Ank1MRI23420/
+-ATTO 495 and wt-ATTO 495 with Ank1
MRI23420/+-ATTO
633 at a ratio of 1:1 and diluted with 1x MT-PBS to a cell
concentration of 1610
9 cells/mL. 0.1 mL from each blood
combination was injected intraperitoneal into separated groups
of infected wt and Ank-1
MRI23420/+ mice in the evening. The day of
cell labelling and injection was chosen when parasitemia of
infected mice was still similar between both cohorts at day 6 or 7
post inoculation (2–4%) as observed on giemsa stained blood
smears. The next day, early morning, one drop of blood from
mouse tail was collected into FACS buffer (1% BSA, 0.1% Sodium
Azide in 1x MT-PBS) and stained with TER119-PE (BD
Biosciences PharMingen) and Hoechst 23580. Samples were
analysed using flow cytometry (FACS Canto II, BD Biosciences
PharMingen). This involved gating all events for TER119+ve.
From this gate the rate of double positive (ATTO 633+
Hoescht23580) out of the total ATTO-633 and the rate of the
double positive (ATTO 495+ Hoescht23580) to the total number
of total ATTO-495 for each recipient strain (SJL and Ank-1
23420/+)
was calculated. In wt mice the combined means of wt (double
positive for either TER119+ ATTO 633+ Hoescht23580 or
TER119+ ATTO 495+ Hoescht23580) and Ank-1
MRI23420/+
(double positive for either TER119+ ATTO 633+ Hoescht23580
or TER119+ ATTO 495+ Hoescht23580) infected RBCs were
expressed as 100% and the proportion of infected RBCs for each
cohort were calculated. The same comparison was repeated
separately in infected Ank-1
MRI23420/+ mice.
Terminal Deoxynucleotidyl Transferase dUTP Nick End
Labeling (TUNEL)
Blood smears from the mouse tail were fixed in 100% MeOH.
For all TUNEL staining an APO-BrdU TUNEL assay kit was
used (Invitrogen). Slides were initially washed 3 times with 1 ml of
wash buffer solution before incubated with 50 ml of DNA labelling
solution mix (according to manufacturer instructions) overnight at
room temperature. The next day slides were rinsed 3 times with
1 ml rinse solution with 2 minutes incubation time each. Stain
sections were then incubated with 100 ml of BrdU-antibody for 1
hour in the dark at room temperature with subsequent washes in
1%BSA/1x MT-PBS (3 times with 2 minutes soaks each). Slides
were then further labelled with 100 ml of nuclear yellow
(Invitrogen) (1:5 `000 in 1% BSA/1 6 MT-PBS) for 1 minute in
the dark. After further washes with 1 ml MT-PBS (3 times with 2
minutes soaks each) sections were affixed with Fluorescent
Mounting Medium (DakoCytomation). Once the medium dried,
slides were examined on an upright epifluorescence microscope
(Olympus BX50) between 600x and 1000x magnification. At least
100 nuclear yellow positive parasites present inside red blood cells
were counted per slide. They were identified as having DNA
fragmentation if they also stained positive for TUNEL.
Quantification of Pyknotic Intracellular Parasites
The percentage of pyknotic vs. healthy looking intracellular
parasites were calculated under a light microscope at 100x
magnification. In contrast to healthy ring parasites (6–8 hour post-
invasion) displaying a big (1/4–1/5 of RBC size) ring body form
(Fig. 7A), ring stage parasites expressing a pyknotic phenotype
(Fig. 7B) were defined if their body size is either below #1/4 the
size of a RBC or lack a classic ring form. Pyknotic parasites 18–20
hour post-invasion (Fig. 7D) were identified if they exhibited a
similar small (#1/4 the size of a RBCs), dense, and irregular body
shape lacking a clear cross-hatch or similar line pattern as opposed
to healthy trophozoites (Fig. 7C).
Statistical Analysis
If not otherwise mentioned all statistical analyses were evaluated
with a Mann-Whitney-Wilcoxon test under R.2.15.0 (http://cran.
r-project.org/).
Supporting Information
Figure S1 Gene expression level of Ank-1
MRI23420/+ and
wild type mice in the spleen, liver, kidney and brain. (A)
Ank-1 primers spanning the exons 6 and 7 upstream and (B)
downstream (exons 17 and 18) of mutation. Error bars indicate
SEM and (*) statistical differences were indicated by * with a p-
value ,0.05.
(TIF)
Figure S2 H & E stained spleen tissue from uninfected
wt and Ank-1
MRI23420/+ mice. Spleen section from uninfected
(A) wt and (B) heterozygous mice with a reduced medulla and a
proliferation of the extramedullar compartment.
(TIF)
Figure S3 Uninfected Ank-1
MRI23420/+ mice exhibit an
iron overload phenotype in the spleen. Histology and Perl `s
blue Prussian staining for iron in (A) wt and (B) Ank-1
MRI23420/+
spleens. (C) Colourimetric analysis of non-heme iron in spleen and
liver from uninfected Ank-1
MRI23420/+ and wt mice. Error bars are
presented as SEM and (*) indicate statistical differences with a p-
value ,0.05.
(TIF)
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ing to invasion/growth in-vivo assay. (A) Quantification of
infected Ank-1
MRI23420/+ (ATTO 633 & Hoechst 34580+ve) and wt
(ATTO 495 & Hoechst 34580+ve) RBC `s in (A) Ank-1
MRI23420/+
and (B) wt host mice.
(TIF)
Figure S5 Parasitemia curve between Ank-1
MRI23420/+
and wt mice corresponding to the TUNEL experiment.
Blood was collected from infected mice (dose 4610
4 iRBC) at the
same time as for the time points used in the TUNEL experiment
including a day after. Error bars are presented as SEM and (*)
indicate statistical differences with a p-value ,0.05.
(TIF)
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